SNSubina Narang

Subina Narang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Subina Narang has a total of 101 co-authors. Here are the top co-authors by number of shared publications:

  • Sunandan Sood

    Departments of Ophthalmology, Government Medical College and Hospital, Chandigarh, India

    11 shared publications
  • Deepak Chawla

    Department of Neonatology, Government Medical College and Hospital, Chandigarh, India

    5 shared publications
  • Meenakshi Sindhu

    Department of Ophthalmology, Government Medical College and Hospital, Chandigarh, India

    5 shared publications
  • Suksham Jain

    Department of Neonatology, Government Medical College and Hospital, Chandigarh, India

    5 shared publications
  • Mannat Giran

    Department of Ophthalmology, Government Medical College and Hospital, Chandigarh, India

    4 shared publications
  • Ravinder Kaur

    Department of Radiology, Government Medical College and Hospital, Chandigarh, India

    4 shared publications

Latest Publications

  • Open Access

    Combined retinal vascular occlusion and optic neuritis revealing systemic lupus erythematosus: A case report

    by Varnika Aditi Singh, Subina Narang, Laxmi Tuli, Navdeep Kaur

    Systemic Lupus Erythematosus (SLE) is a multisystem autoimmune disorder that rarely presents with catastrophic ocular ischemia as its primary manifestation. We report an aggressive onset of SLE in a 45-year-old female with Tetralogy of Fallot, presenting with sudden profound painful vision loss in the right eye (perception of light), generalized weakness, and inability to bear weight on lower limbs (flaccid quadriparesis). Ophthalmic evaluation revealed combined central retinal artery and vein occlusion, confirmed by FFA. She also had fever and delirium. Systemic workup confirmed SLE. She was started on intravenous steroids and oral anticoagulants, leading to progressive systemic improvement. This case underscores the rarity of combined neuro-ophthalmic ischemia and motor weakness as an initial presentation of SLE, necessitating urgent multisystem intervention.

  • Open Access

    Rapid resolution of choroidal metastases after Iodine-25 plaque brachytherapy using OcuProsta seeds

    by Subina Narang, Arushi Aggarwal, Navya Naveen Kalra, Gurbir Gill

    A patient presenting with a subretinal mass lesion with exudative retinal detachment prompts us to work up the case for an infective, inflammatory, or metastatic cause. A 55-year-old female, five years after successful treatment for esophageal adenocarcinoma, presented with diminution of vision in the left eye. Her ocular examination showed a well-defined subretinal mass lesion with exudative retinal detachment. Radiological investigations were suggestive of an enhancing choroidal metastatic lesion. After a thorough systemic examination to rule out any other systemic metastasis, inflammatory and infective pathology, the patient received iodine-125 brachytherapy for the left eye for 48 hours. The follow-up visit in the subsequent week showed remarkable flattening of the lesion with resolution of retinal detachment. This is the first well-documented case of esophageal metastasis showing rapid resolution with OcuProsta seeds, which are iodine-125 seeds designed by Bhabha Atomic Research Institute.

  • Corneoscleral plaque brachytherapy using ‘BARC I-125 Ocu-Prosta seeds’ in the management of iridociliary melanoma

    by Ujjwal Prakash Jha, Subina Narang, Varsha Jindal

    We present the case of a woman in her late 40s who presented with an iris lesion extending to the ciliary body and mature white cataract with a visual acuity of perception of light in her right eye. The tumour was managed with Bhabha Atomic Research Centre Iodine-125 (BARC I-125) Ocu-Prosta seeds plaque therapy with the amniotic membrane buffer technique. No corneal complications or secondary glaucoma were seen over a 6-month follow-up, and a reduction in tumour size was observed on MRI. Ten months post corneoscleral plaque brachytherapy (PB), the patient underwent phacoemulsification in the same eye and achieved a best corrected visual acuity of 20/40. This case highlights the use of cost-effective indigenous I-125 Ocu-Prosta seeds with amniotic membrane in the successful management of iridociliary melanoma, which has not been reported so far.

  • Open Access

    Cogan’s syndrome presenting as bilateral scleritis

    by Subina Narang, Anusuya Bhattacharyya, Unnati Sharma, Daljinder Kaur

    Cogan’s syndrome is a rare autoimmune disease classified under primary variable vessel vasculitis with variable systemic presentations. Due to nonavailability of specific diagnostic test, diagnosis becomes a challenge and clinical diagnosis is the mainstay of diagnosis. In this article, we report a case of Cogan’s syndrome presenting as bilateral scleritis. Detailed history and general physical examination revealed hearing loss, tinnitus, and aortic regurgitation. The patient was successfully treated with corticosteroids, cyclophosphamide, and mesna (sodium 2-mercaptoethanesulfonate), which gave a good recovery. The patient is free of any recurrence till the longest follow-up period of 36 months. Our findings suggest that strong clinical suspicion with the initiation of early immunosuppressive therapy leads to a favorable outcome in Cogan’s syndrome.


  • Open Access

    Fractionated external beam radiation therapy for refractory diffuse choroidal hemangioma

    by Subina Narang, Mahima Kansal, Laxmi Tuli, Divya Khosla

    We report a case of a young male with Sturge–Weber syndrome presenting with bilateral diffuse choroidal hemangioma (DCH) and left eye exudative retinal detachment (ERD). Plaque brachytherapy was done for the left eye; 1 week later, the right eye vision dropped due to ERD, for which external fluid drainage was attempted, but failed. Treatment with oral propranolol followed by photodynamic therapy with verteporfin was given for the right eye. After a brief period of resolution, recurrence was noted. Then, the eye was subjected to fractionated external beam radiotherapy, which turned out to be an effective treatment in such a refractory case, preserving vision with no recurrence on follow-up.

  • Long-term sequelae of stage 4A ROP after successful management with lens-sparing vitrectomy

    by Sonia Bariya, Subina Narang, Varsha Jindal, Reetika Negi

    We present an unusual case of a macular lesion, possibly a spontaneously closed macular hole, at a 4-year follow-up visit, after lens-sparing vitrectomy (LSV) in stage 4A retinopathy of prematurity (ROP). Optical coherence tomography scans of the macula were suggestive of a spontaneously closed macular hole and fibrovascular proliferation at the equator. We hypothesise that tangential traction by residual posterior hyaloid could lead to late macular hole formation after LSV in ROP. There is a need to document this finding as this could throw some light on the late sequelae of LSV.


  • Open Access

    Sudden visual loss after COVID-19 infection with diabetic ketoacidosis

    by Laxmi Tuli, Subina Narang, Mahima Kansal, Nitesh Dhayal

    We report a case of an atypical optic neuritis (AION) in an adolescent male, diagnosed with diabetic ketoacidosis in the setting of a coronavirus disease 2019 (COVID-19) infection. On the third day of admission, he developed sudden profound visual loss and ocular examination revealed bilateral pale disc edema. Examination and investigations were conclusive of bilateral optic neuritis. Optic neuritis in the setting of pale disc edema was unusual, and the pallor could be due to an episode of AION that was superadded by optic neuritis during the cytokine storm. The patient was given a trial of i.v. steroids. However, the vision loss could be recovered partially only. Thus, through this case report, we would like to highlight the importance of a close follow-up of patients following COVID-19 infection and a possible association of metabolic acidosis in precipitating the episode of optic neuritis.

  • Open Access

    Iodine-125 brachytherapy for choroidal melanoma by using Ocuprosta seeds with indigenous non-collimated plaques: Our initial experience

    by Subina Narang, Awadesh K Pandey, Gurbir Kaur, Mannat Giran, Sanjay K Saxena, Sandeep Moudgil, Dinesh K Walia, Uma Handa, Vijay K Meena, Ravinder Kaur, et al.

    Purpose: Brachytherapy is the gold-standard treatment for choroidal melanoma. This study evaluated iodine-125 brachytherapy by using Ocuprosta seeds with indigenous non-collimated plaques in Asian patients. Methods: Retrospective single-center study in a tertiary care hospital of 12 eyes with choroidal melanoma in 12 Asian patients who underwent brachytherapy with Ocuprosta seeds fixed on non-collimated plaques and had a follow-up of at least 32 months (mean: 42.4 ± 9.5 months; median: 40 months). Radiotherapy was planned after developing the digital 3D model of the tumor within the eye by using radiological images and clinical pictures. Ocuprosta iodine-125 seeds were used on indigenous non-collimated gold plaques to deliver the radiation for precalculated time. “Successful outcome” was taken as a decrease in the volume of the tumor, and “unsuccessful outcome” was defined as no change in the tumor volume or increase in the tumor volume at 24 months after brachytherapy. Results: The mean decrease in tumor volume was 21% (914.5 ± 912.2 mm 3 to 495.7 ± 633.6 mm 3 ) after brachytherapy, which correlated with the baseline volume of the tumor. Ten eyes (83.3%) showed a reduction in tumor volume, whereas two eyes showed an increase in the volume of the tumor after brachytherapy. One of the cases with a reduction in tumor size developed neovascular glaucoma. Enucleation was done in three eyes. A globe salvage rate of 75% and tumor regression rate of 83% were seen in the present study using Ocuprosta seeds. Conclusions: Iodine-125 brachytherapy with uncollimated indigenous gold plaques is an effective treatment modality for choroidal melanomas in Asian patients.


  • Open Access

    Concomitant multiple subretinal cysticerci in neurocysticercosis

    by Simran Chhabra, Subina Narang, Anusuya Bhattacharyya, Ravinder Kaur

    We present a unique case of asymptomatic NCC that was accidently diagnosed on radiological investigations after a road traffic accident. An Ophthalmologic consult was sought to rule out intraocular or optic nerve cysticercosis. Fundoscopy showed multiple white-pale yellow lesions in the right eye which on ultrasonography confirmed cyst lined by a cyst wall consistent with subretinal cysticercosis. The patient was treated with diode laser photocoagulation. A high index of suspicion is required to diagnose NCCin endemic areas. In the right eye which on ultrasonography confirmed cyst lined by a cyst wall consistent with subretinal cysticercosis. The patient was treated with diode laser photocoagulation.


  • Systemic biomarkers of retinopathy of prematurity in preterm babies

    by Parrina Sehgal, Subina Narang, Deepak Chawla, Seema Gupta, Suksham Jain, Unnati Sharma, Deeksha Katoch, Jasbinder Kaur

    Purpose Retinopathy of prematurity (ROP) progression is an inter-play of various perinatal and neonatal angiogenic and inflammatory cytokines. A small subset of ROP progresses to ROP requiring treatment. The present study was conducted with the aim to determine whether levels of IL-6, IL-8 and VEGF in serum and urine at the time of first ROP screening visit could be a biomarker for the prediction of development of treatable ROP. Method Prospective single-center observational study of preterm babies screened for ROP. Blood and urine samples were collected as a part of routine sampling at initial ROP screening visit and stored at −80 °C for further processing. The babies were followed up and grouped into ‘Group A’ comprising of 35 babies who developed treatable ROP and ‘Group B’ comprising of 36 babies with regressed ROP or no ROP. The evaluation of blood and urine samples was done for IL6, IL8 and VEGF by solid-phase sandwich RayBio® Human ELISA kit. Results The median serum values for IL-6, IL-8 and VEGF in Group A and Group B were 5.8 pg/ml (IQR 1.5,128.5) and 8.7 pg/ml (IQR 1.5,30.5), 55.9 pg/ml (IQR 28.0, 392.9) and 27.0 pg/ml (IQR 20.5,444.9) and 26.6 pg/ml (IQR 6.3, 39.4) and 30.0 pg/ml (IQR9.2,70.3), respectively. Group A had significantly increased levels of IL-8 (p < 0.05). However, AUROC curve for serum IL-8 demonstrated suboptimal discriminating ability. Conclusion Babies developing ROP requiring treatment had significantly increased levels of IL-8 in the serum at the time of initial screening. However, it could not serve as predictor for treatable ROP.